Zhejiang Jolly Pharmaceutical Co.,LTD
SHZ: 300181.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tao Wang
- Employees
- 2,687
- Headquarters
- Huzhou, China
- IPO year
- 2011
- Market cap
- CN¥10.4B
- Website
- https://www.zuoli.com
Loading 300181…
Loading profile data…Frequently asked questions about 300181
What does Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) do?
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and w...
Where does 300181.SZ trade?
Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300181.SZ in?
Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zhejiang Jolly Pharmaceutical Co.,LTD?
Tao Wang is the chief executive officer of Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ).
Where is Zhejiang Jolly Pharmaceutical Co.,LTD headquartered?
Zhejiang Jolly Pharmaceutical Co.,LTD is headquartered in China.
Does 300181.SZ pay a dividend?
Yes — Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) paid a trailing twelve-month dividend of CNY 0.45 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300181.SZ go public?
Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) completed its initial public offering in 2011.